Literature DB >> 33639898

The attenuation of insulin-like growth factor signaling may be responsible for relative reduction in matrix synthesis in degenerated areas of osteoarthritic cartilage.

Nobuho Tanaka1, Hirotaka Tsuno1,2, Satoru Ohashi1,3, Mitsuyasu Iwasawa1,3, Hiroshi Furukawa4, Tomohiro Kato5, Naoshi Fukui6,7.   

Abstract

BACKGROUND: In osteoarthritis (OA), cartilage matrix is lost gradually despite enhanced matrix synthesis by chondrocytes. This paradox may be explained, at least partly, by reduced chondrocyte anabolism in degenerated area of OA cartilage. However, to date, it is not known why chondrocyte anabolism is suppressed in those areas.
METHODS: Cartilage was obtained from control knees and end-stage OA knees in macroscopically preserved areas and degenerated areas, and gene expression was analyzed in respective regions of cartilage using laser capture microdissection and qPCR. For the cartilage protein analysis, cartilage was obtained from preserved areas and degenerated areas of OA knees in pairs, and proteins were extracted using urea buffer. Protein concentrations were determined by Luminex and compared between the areas. Cartilage explants prepared from preserved areas and degenerated areas of OA knees were cultured in the presence or absence of an AKT inhibitor, and the gene expression was evaluated by qPCR. Finally, the expression of SP1 was evaluated in OA and control cartilage, and the significance of Sp1 on the expression of IGF1R and IRS1 was investigated in experiments using primary cultured chondrocytes.
RESULTS: Within OA cartilage, the expression of IGF-1, IGF-2, IGF1R and IRS1 was reduced in degenerated areas compared to preserved areas, while the expression of all six IGF-binding protein genes examined was enhanced in the former areas. Consistent results were obtained by a protein analysis. In explant culture, the inhibition of AKT signaling abrogated the abundant matrix gene expression in the preserved areas over the degenerated areas, indicating that suppressed matrix synthesis in degenerated areas may be ascribed, at least partly, to attenuated IGF signaling. Within OA cartilage, the expression of Sp1 was considerably reduced in severely degenerated areas compared to preserved areas, which correlated well with the expression of IGF1R and IRS1. In experiments using primary cultured chondrocytes, the expression of IGF1R and IRS1 was enhanced by the induction of Sp1 expression and reduced by the suppression of Sp1 expression.
CONCLUSIONS: The results of this study suggest that attenuated IGF signaling may be responsible, at least partly, for the reduced matrix synthesis in degenerated areas of OA cartilage.

Entities:  

Keywords:  Chondrocyte; IGF; IGF1R; IRS1; Laser capture microdissection; Matrix synthesis; Osteoarthritis; Sp1

Mesh:

Substances:

Year:  2021        PMID: 33639898      PMCID: PMC7916266          DOI: 10.1186/s12891-021-04096-w

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  34 in total

1.  Damage control mechanisms in articular cartilage: the role of the insulin-like growth factor I axis.

Authors:  J A Martin; M B Scherb; L A Lembke; J A Buckwalter
Journal:  Iowa Orthop J       Date:  2000

2.  Normal expression of type 1 insulin-like growth factor receptor by human osteoarthritic chondrocytes with increased expression and synthesis of insulin-like growth factor binding proteins.

Authors:  G Tardif; P Reboul; J P Pelletier; C Geng; J M Cloutier; J Martel-Pelletier
Journal:  Arthritis Rheum       Date:  1996-06

3.  αvβ5 integrin promotes dedifferentiation of monolayer-cultured articular chondrocytes.

Authors:  Naoshi Fukui; Yasuko Ikeda; Nobuho Tanaka; Masahiro Wake; Tetsuo Yamaguchi; Hiroyuki Mitomi; Satoru Ishida; Hiroshi Furukawa; Yoshiki Hamada; Yoshinari Miyamoto; Motoji Sawabe; Toshiyuki Tashiro; Yozo Katsuragawa; Shigeto Tohma
Journal:  Arthritis Rheum       Date:  2011-07

4.  Laser capture microdissection.

Authors:  M R Emmert-Buck; R F Bonner; P D Smith; R F Chuaqui; Z Zhuang; S R Goldstein; R A Weiss; L A Liotta
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

Review 5.  Transcriptional and epigenetic control of IGF1R gene expression: implications in metabolism and cancer.

Authors:  Haim Werner; Rive Sarfstein
Journal:  Growth Horm IGF Res       Date:  2014-05-09       Impact factor: 2.372

6.  Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology.

Authors:  T Aigner; A Zien; A Gehrsitz; P M Gebhard; L McKenna
Journal:  Arthritis Rheum       Date:  2001-12

7.  The insulin-like growth factor binding proteins in uncultured human cartilage: increases in insulin-like growth factor binding protein 3 during osteoarthritis.

Authors:  Teresa I Morales
Journal:  Arthritis Rheum       Date:  2002-09

8.  Zonal gene expression of chondrocytes in osteoarthritic cartilage.

Authors:  Naoshi Fukui; Yoshinari Miyamoto; Masahiro Nakajima; Yasuko Ikeda; Atsuhiko Hikita; Hiroshi Furukawa; Hiroyuki Mitomi; Nobuho Tanaka; Yozo Katsuragawa; Seizo Yamamoto; Motoji Sawabe; Takuo Juji; Toshihito Mori; Ryuji Suzuki; Shiro Ikegawa
Journal:  Arthritis Rheum       Date:  2008-12

9.  Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants.

Authors:  F P Luyten; V C Hascall; S P Nissley; T I Morales; A H Reddi
Journal:  Arch Biochem Biophys       Date:  1988-12       Impact factor: 4.013

Review 10.  The regulation of IGF-I receptor gene expression.

Authors:  H Werner; C Hernández-Sánchez; E Karnieli; D Leroith
Journal:  Int J Biochem Cell Biol       Date:  1995-10       Impact factor: 5.085

View more
  1 in total

1.  Fetal Immunomodulatory Environment Following Cartilage Injury-The Key to CARTILAGE Regeneration?

Authors:  Iris Ribitsch; Andrea Bileck; Monika Egerbacher; Simone Gabner; Rupert L Mayer; Lukas Janker; Christopher Gerner; Florien Jenner
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.